3.8 C
London
Saturday, November 27, 2021
HomeAll ArticlesPfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11

Pfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11

Pfizer Inc (PFE.N) and BioNTech SE have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Thursday.

Reporting by Susan Heavey in Washington and Manas Mishra and Manojna Maddipatla in Bengaluru; Editing by Will Dunham, Timothy Heritage and Saumyadeb Chakrabarty (Reuters)

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments

    WP2Social Auto Publish Powered By : XYZScripts.com